503 related articles for article (PubMed ID: 15368150)
41. Predictors of arm morbidity following breast cancer surgery.
Hack TF; Kwan WB; Thomas-Maclean RL; Towers A; Miedema B; Tilley A; Chateau D
Psychooncology; 2010 Nov; 19(11):1205-12. PubMed ID: 20099254
[TBL] [Abstract][Full Text] [Related]
42. Lymphedema and quality of life in Chinese women after treatment for breast cancer.
Mak SS; Mo KF; Suen JJ; Chan SL; Ma WL; Yeo W
Eur J Oncol Nurs; 2009 Apr; 13(2):110-5. PubMed ID: 19246241
[TBL] [Abstract][Full Text] [Related]
43. Arm morbidity and disability after breast cancer: new directions for care.
Thomas-Maclean RL; Hack T; Kwan W; Towers A; Miedema B; Tilley A
Oncol Nurs Forum; 2008 Jan; 35(1):65-71. PubMed ID: 18192154
[TBL] [Abstract][Full Text] [Related]
44. Erysipelas of the upper extremity following locoregional therapy for breast cancer.
El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO
Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307
[TBL] [Abstract][Full Text] [Related]
45. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
46. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
47. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
48. Carpal Tunnel Syndrome Management in Breast Cancer Survivors at Risk for Lymphedema: A Markov Model.
Retrouvey H; Krahn M; Baltzer HL
Plast Reconstr Surg; 2018 May; 141(5):689e-696e. PubMed ID: 29697616
[TBL] [Abstract][Full Text] [Related]
49. Incidence and risk factors of breast cancer lymphoedema.
Park JH; Lee WH; Chung HS
J Clin Nurs; 2008 Jun; 17(11):1450-9. PubMed ID: 18482142
[TBL] [Abstract][Full Text] [Related]
50. [Incidence and risk factors of lymphedema in women after surgery for breast cancer].
Doś J; Gutowski P; Górska-Doś M
Ann Acad Med Stetin; 2009; 55(2):30-4. PubMed ID: 20349609
[TBL] [Abstract][Full Text] [Related]
51. Case-control study to evaluate predictors of lymphedema after breast cancer surgery.
Swenson KK; Nissen MJ; Leach JW; Post-White J
Oncol Nurs Forum; 2009 Mar; 36(2):185-93. PubMed ID: 19273407
[TBL] [Abstract][Full Text] [Related]
52. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system.
Manouras A; Markogiannakis H; Genetzakis M; Filippakis GM; Lagoudianakis EE; Kafiri G; Filis K; Zografos GC
Arch Surg; 2008 Jun; 143(6):575-80; discussion 581. PubMed ID: 18559751
[TBL] [Abstract][Full Text] [Related]
53. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
54. Precipitating factors for lymphedema following surgical treatment of breast cancer: implications for patients undergoing axillary lymph node dissection.
Dayangac M; Makay O; Yeniay L; Aynaci M; Kapkac M; Yilmaz R
Breast J; 2009; 15(2):210-1. PubMed ID: 19292814
[No Abstract] [Full Text] [Related]
55. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
56. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
57. Tissue expander breast reconstruction is not associated with an increased risk of lymphedema.
Avraham T; Daluvoy SV; Riedel ER; Cordeiro PG; Van Zee KJ; Mehrara BJ
Ann Surg Oncol; 2010 Nov; 17(11):2926-32. PubMed ID: 20499284
[TBL] [Abstract][Full Text] [Related]
58. Surgical treatment of early breast cancer in day surgery.
Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
[TBL] [Abstract][Full Text] [Related]
59. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
[TBL] [Abstract][Full Text] [Related]
60. Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery.
Mathew J; Barthelmes L; Neminathan S; Crawford D
Eur J Surg Oncol; 2006 Sep; 32(7):729-32. PubMed ID: 16777367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
